Suggestions
Jose Bonafont
Gene and Cell Therapy | Hematology | Scientific Advisor | Clinical Trials | GMP | Process Development | Technical Writing
Jose Bonafont is a Principal Scientist specializing in Research and Process Development at DanausGT, a biotechnology company based in Madrid, Spain. He has over ten years of experience in advanced therapies aimed at treating rare disorders. His current work involves developing gene editing strategies, particularly using the CRISPR-Cas9 system, to address genetic conditions such as recessive dystrophic epidermolysis bullosa (RDEB), which is caused by mutations in the COL7A1 gene.13
Bonafont has contributed to significant research in genome editing, presenting innovative approaches to correct genetic mutations and restore the production of essential proteins in affected patients. His expertise is particularly noted in the application of gene editing technologies for therapeutic purposes, which he has discussed at various scientific conferences.125
In addition to his research, Bonafont is actively involved in clinical trials, specifically in Phase I/II studies, focusing on the translation of gene therapy concepts into practical treatments for patients.34
